Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Close this folder13. Partnership and collaboration
View the document13.1 The importance of supportive partners
View the document13.2 Possibilities at national, regional and international levels
Close this folder13.3 Various forms of collaboration
View the document13.3.1 Twinning arrangements
View the document13.3.2 Sharing information and resources
View the document13.3.3 Using established bulletins’ expertise
View the document13.3.4 Training sessions and workshops
View the document13.3.5 Ongoing information exchange between bulletins
View the document13.3.6 Collaborative research among bulletins
View the document13.3.7 Information and support for funding applications
View the document13.4 Identifying partners and networks
View the document13.5 Clearly define conditions for partnership
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

13.3.1 Twinning arrangements

A twinning arrangement is a one-to-one relationship of support between an established bulletin and a small or newly formed bulletin. Some drug bulletins in Western countries have more than 30 years of experience. Their knowledge of work organization, the editorial process, dissemination of the drug bulletin, financing and fundraising are valuable resources. Even if it is necessary or more appropriate to do things differently in your country, you are likely to gain a lot from this wealth of experience. Developing twinning arrangements between one of the experienced journals and a new or small drug bulletin can benefit both partners. It can also stimulate an established bulletin to learn about pharmaceutical issues new to them or to view their own national situation in a new light.

Some twinning arrangements are particularly successful between bulletins sharing the same language or close languages (e.g. la revue Prescrire, France and La Lettre du Cedim, Burkina Faso; la revue Prescrire, and Dialogo sui Farmaci, Italy). Other examples have been successful despite linguistic differences.

Such twinning arrangements can be organized directly or through ISDB. A systematic approach to this type of support helps to ensure that the arrangement benefits both partners. One type of twinning programme is on-the-job training for new editors. The steps for developing such an arrangement would be to:

• identify needs;
• identify who can provide the needed support;
• establish contact with the organizations or institution;
• reach either a formal or informal agreement about collaboration;
• review and revise the agreement periodically.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017